Study Confirms Higher blood clots risk with Newer Birth Control Pills

28 (PRWEB) October 2011 A study on 25 Was published in October 2011 by the British Medical Journal confirmed earlier findings that certain oral contr...


28 (PRWEB) October 2011

A study on 25 Was published in October 2011 by the British Medical Journal confirmed earlier findings that certain oral contraceptives, the newer types of progestogen hormones (drospirenone, desogestrel or gestodene), which found in Yaz or Yasmin, at least twice the risk of developing venous thromboembolism (VTE ) compared with oral contraceptives with an older progestin hormone (levonorgestrel) says attorney David Ennis.

Dr. Ojvind Lidegaard of the University of Copenhagen, led the large-scale study, the more than 1.2 million non-pregnant, 15 contain -. to 49-year-old women in Denmark without a history of thrombotic disorders The study showed that women. On the pill with the older, levonorgestrel version to three times the risk of VTE than those who were not on any hormonal contraception However, oral contraceptives containing desogestrel, gestodene, drospirenone or cyproterone acetate increased the risk about 6-7 times that of non-users. The researchers explain that. Newer forms of progesterone in combination hormonal contraceptives clearly the much higher risk of VTE than older forms

Meanwhile, the U.S. Food and Drug Administration (FDA) already. studying the possible increased risk of blood clots with pills, drospirenone the The FDA says its preliminary results indicate a 1.5-fold increased risk compared to other hormonal contraceptives, about 10 women in 10,000 from 6 women in 10,000. Because of these conflicting data, the FDA has a joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on 8 December 2011 planned.

VTE is a blood clot that forms within a vein and can travel to the lungs, which can be fatal. Symptoms of blood clots include persistent leg pain, severe chest pain, or sudden shortness of breath.

Attorney David Ennis recommends that women have taken drospirenone-containing birth control pills and experienced any of these symptoms should first discuss with their doctor immediately. Next, the patient should one MedWatch form to fill http://www.fda.gov. Finally, patients should seek the opinion of an experienced lawyer to explore their rights.

Ennis & Ennis P.A. offering free nationwide confidential consultations for patients who have taken or under drosepirenone-containing medications and suffer these symptoms by calling toll-free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online In evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington DC Ennis & Ennis, PA concentrates its practice in mass torts clause and represents individuals against pharmaceutical companies worldwide, as well as medical device manufacturers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $ 100 million in settlements for its clients.

Ennis & Ennis, P.A. also investigated cases, Accutane, Actos, Avandia, Fosamax, Paxil, Zoloft, Prozac, Depuy Hip Recall, Hip Recall room, Depakote, Reglan, SJS / Dilantin, Yaz, Yasmin, Ocella birth control pills and transvaginal mesh devices.

Remember the law limits the time in which you can file a lawsuit, so do not wait to explore your legal rights. Call today toll free 1-800-856-6405 or visit http://www.ennislaw.com.

# # #


Leave a Reply